Are you currently facing long drug development cycles, difficulty in achieving high-purity dual-specific molecules, and challenges in overcoming tumor tissue barriers? Our Bispecific Antibody (BsAb) Fragments Generation Services help you accelerate lead candidate identification and streamline biotherapeutic development through advanced High-Throughput (HTP) combinatorial screening platforms and precision fragment engineering. Creative Biolabs delivers clinical candidates optimized for stability and efficacy.
Contact our team to get an inquiry now!
Bispecific Antibodies (BsAbs) represent a significant leap in targeted biotherapeutics due to their ability to engage two distinct targets simultaneously. BsAb fragments (50-100 kDa) are strategically engineered scaffolds that offer a clinical advantage over bulky full-length IgGs: their smaller size ensures superior tissue penetration, essential for reaching targets within solid tumors. Unlike BsIgG, fragment molecules inherently lack Fc-mediated effector functions (such as ADCC or CDC), which can be a deliberate design choice to minimize non-specific immune activation or clearance. Structurally, these fragments overcome the production complexities (like chain mispairing) associated with full IgGs by using stable, non-IgG architectures.
Fig.1 Formats of bispecific antibodies.1
For improved pharmacokinetics (PK), Creative Biolabs designs advanced fragments that may strategically incorporate constant region components, like the CH3 domain, specifically to enhance heterodimer formation and increase the molecular half-life via FcRn interaction, all while maintaining the fragment's non-effector profile. We specialize in these high-purity fragment scaffolds, including T-cell Engagers (TCEs) and Killer Cell Engagers (BiKEs/TriKEs), providing a direct path to potent new medicines.
Creative Biolabs uses advanced techniques to generate a wide variety of Bispecific Antibody (BsAb) Fragments. The Bispecific Antibody (BsAb) Fragments mainly include:
Creative Biolabs leverages specialized expertise in bioconjugation and fragment design to bypass the purity and efficacy challenges of full-length IgG bispecifics. We solve the industry's discovery bottleneck using High-Throughput (HTP) combinatorial screening, ensuring lead candidates are selected for function and manufacturability. Our unique advantages ensure the fragments we deliver are optimized for the clinic:
Experience the Creative Biolabs Advantage - Get a Quote Today
A: BsAb fragments, such as Diabodies and Tandem scFvs, are structurally simpler and bypass the inherent challenges of heavy/light chain mispairing common in full IgG bispecifics (like Knobs-in-Holes). Creative Biolabs' process utilizes fragment-specific engineering and rigorous LC-MS analytics to ensure our fragments achieve significantly higher purity and lower aggregation than typical IgG formats.
A: For T-cell recruitment, we often recommend Bispecific T-Cell Engagers and Dual-Affinity Retargeting formats, frequently based on Diabody or Tandem scFv structures. For Natural Killer (NK) cell recruitment, we use specialized BiKE and TriKE designs targeting CD16. We tailor the exact scaffold to match your target combination.
A: Absolutely. While smaller fragments offer superior penetration, they clear rapidly. We offer advanced half-life extension strategies, notably the fusion of the fragment to serum albumin or specific domains that facilitate FcRn-mediated recycling, allowing us to tune the half-life to your therapeutic needs without compromising penetration.
A: Our final lead candidates are rigorously characterized using advanced Liquid Chromatography hyphenated with Mass Spectrometry (LC-MS). This includes methods like HIC and IEX to precisely quantify and confirm the correctly assembled bispecific product and ensure the purity levels required for successful preclinical studies.
A: Yes. The small size and versatile design of BsAb fragments makes them instrumental in developing therapeutics aimed at traversing the BBB, which is a major limitation for full IgG molecules. We can assist in designing fragments with specific characteristics to maximize passive or active transport across this barrier.
Reference
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY
SERVICES
PRODUCTS
PLATFORMS
